Skip to content

BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy

By growthzone | April 8, 2022 | Comments Off on BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy

BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the Biogen’s Alzheimer’s disease treatment Aduhelm — along with other drugs like it — to clinical trials. Michelle McMurry-Heath, M.D., Ph.D., president and…

Read More

Legislative Life Sciences Caucus

By growthzone | March 15, 2021 | Comments Off on Legislative Life Sciences Caucus

Legislative Life Sciences Caucus Life Sciences Caucus Documents 2024 Meetings May 1 North Carolina’s Innovation Ecosystem May 1 North Carolina’s Innovation Ecosystem Invitation Presentation FY25 One NC Small Business Program Funding Request The Life Sciences Caucus of the NC General Assembly met for the first time in 2024 at the NC Department of Commerce at…

Read More